100
Participants
Start Date
December 27, 2023
Primary Completion Date
January 31, 2027
Study Completion Date
January 31, 2027
Apalutamide
Standard of care Apalutamide 240 mg administered orally and daily on Days 1-28 of every 28 day cycle
Carotuximab
"Carotuximab administered intravenously at the following doses:~Cycle 1 Day 1: 3 mg/kg Cycle 1 Day 4: 7 mg/kg Cycle 1 Day 8: 10 mg/kg Cycle 1 Day 15: 10 mg/kg Cycle 1 Day 22: 10 mg/kg Cycle 2 Day 1: 15 mg/kg Cycle 2 Day 15: 15 mg/kg Cycle 3+ Day 1: 15 mg/kg After completion of cycle 2, dosing of carotuximab will continue at a q4 week schedule using the 15 mg/kg dose."
RECRUITING
Huntsman Cancer Institute and Hospital, Salt Lake City
RECRUITING
Cedars-Sinai Medical Center, Los Angeles
RECRUITING
City of Hope, Duarte
Collaborators (1)
Enviro Therapeutics, Inc.
UNKNOWN
Edwin Posadas, MD
OTHER